Yeast Infection Treatment Market: Increase in Incidence of Yeast Infection to Drive the Market
Yeast Infection Treatment Market: Introduction
Yeast Infection, also known as candiasis, is a common type of fungal infection. Yeast infection occurs on various parts of the human body such as skin, oral cavity, and intestines. Vaginal yeast infection is highly common and is widely prevalent among women and is known as candidal vaginitis or candidal vulvovaginitis (CVV). Candida Albicans is the most common fungus responsible for vaginal yeast infection.
Read Report Overview - https://www.transparencymarketresearch.com/yeast-infection-treatment-market.html
Few symptoms of the vaginal yeast infection are itching, burning, swelling, rashes, and redness, and the underlying reasons responsible are prolonged antibiotic usage, lack of hygiene, lifestyle disease, and compromised immunity. All these factors are estimated to drive the need for treatment of various yeast infection. Increasing burden of ailments such as cardiovascular, gastrointestinal, and other disease is also a key factor that is estimated to boost the yeast infection treatment market during the forecast period.\
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=42134
Key Drivers, Restraints, and Opportunities of Yeast Infection Treatment Market
Increase in incidence of yeast infection, emergence of new fungal infections, increase in usage of the antibiotics which makes the yeast infection resistant to it, and increasing research & development on yeast infection are major factors that are projected to propel the market during the forecast period. As per various clinical studies, 75% of women are likely to acquire yeast infection once or twice in their lifetime. Moreover, vaginal yeast infections are the second-most common reason for abnormal vaginal discharge in the U.S.
As per NCBI research, in 2017, yeast infection accounted for 1 billion people suffering from skin, nail, and hair fungal infections with 10 million suffering from mucosal candiadiasis and 150 million population suffering from serious fungal diseases. Rising prevalence of HIV/AIDS pandemic, chronic obstructive pulmonary disease, asthma, and growing incidence of cancers are a few factors that are anticipated to fuel the yeast infection treatment market during the forecast period.
Request for Analysis of COVID-19 Impact on Yeast Infection Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=42134
As per NCBI studies, in 2018, approx., 30% to 50% of women were affected by vulvovaginal candidiasis once in their lifetime. In Germany, 40% of women reported cases of vulvovaginal candidiasis in 2018. Candida species is the most common yeast infection identified in Asia Pacific. Candidemia is the most common type of invasive candidiasis with an incidence rate of 0.05- 0.36 per 1000 population in Australia. All these statistics are likely to boosts the yeast infection treatment market during the forecast period.
North America to Dominate Global Yeast Infection Treatment Market
North America accounted for a prominent share in yeast infection treatment market followed by Europe region. Rise in yeast infection and number of cases of vaginal infections is a key factor driving the market in the region. Moreover, increase in burden of the urology patient population, advanced healthcare infrastructure, and favorable reimbursement scenarios in the region are a few factors that are likely to boosts the yeast infection treatment market in North America.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=42134
As per Centers for Disease Control and Prevention, vaginal candidiasis is the second-most common infection in the U.S. with estimated 1.4 million outpatient visits occurring annually in the country
In Europe, the yeast infection treatment market is estimated to follow the market in North America, attributable to the rising incidences of yeast infection, growing cases of vaginal infection in women patient population, and introduction of new treatment options for yeast infections
The rise in number of fungal species infections, such as Candida auris infections, is at its peak, which is a major concern for the healthcare settings in Europe. This drives the demand for yeast infection treatment in the region.
Pre Book Yeast Infection Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=42134<ype=S
Key Companies of Yeast Infection Treatment Market
- Astellas Pharma Inc
- Astra Zeneca
- Abbott Laboratories
- Brundavan Laboratories Private Limited
- Corden Pharma
- Merck & Co., Inc.
- Pfizer Inc
- Synmedic Laboratories
- Other Prominent Players
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Mr. Rohit Bhisey
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453